FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

STEVENS DAVID D
2. Issuer Name and Ticker or Trading Symbol

Wright Medical Group N.V. [ WMGI ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

1023 CHERRY ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)

11/11/2020
(Street)

MEMPHIS, TN 38117
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares, par value EUR 0.03 per share 11/11/2020  U(1)  99666 D$30.75 0 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy) $27.84 11/11/2020  D     11691   (2)7/26/2029 Ordinary Shares 11691  (2)0 D  
Stock Option (right to buy) $24.49 11/11/2020  D     9907   (2)7/24/2028 Ordinary Shares 9907  (2)0 D  
Stock Option (right to buy) $27.86 11/11/2020  D     10275   (2)7/25/2027 Ordinary Shares 10275  (2)0 D  
Stock Option (right to buy) $21.24 11/11/2020  D     11765   (2)7/19/2026 Ordinary Shares 11765  (2)0 D  
Stock Option (right to buy) $20.62 11/11/2020  D     11018   (2)10/13/2025 Ordinary Shares 11018  (2)0 D  
Stock Option (right to buy) $29.06 11/11/2020  D     10309   (2)5/13/2024 Ordinary Shares 10309  (2)0 D  
Stock Option (right to buy) $23.93 11/11/2020  D     10309   (2)5/14/2023 Ordinary Shares 10309  (2)0 D  

Explanation of Responses:
(1) On November 4, 2019, Wright Medical Group N.V. (the Issuer) entered into a purchase agreement (the Purchase Agreement) with Stryker Corporation and its subsidiary, Stryker B.V. (the Purchaser). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (Shares), of the Issuer (the Offer), and on November 11, 2020 (the Acceptance Time), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer, including 99,666 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the Offer Consideration), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement).
(2) Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
STEVENS DAVID D
1023 CHERRY ROAD
MEMPHIS, TN 38117
X



Signatures
/s/ Marija Nelson, attorney-in-fact11/13/2020
**Signature of Reporting PersonDate

Wright Medical Group NV (NASDAQ:WMGI)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Wright Medical Group NV Charts.
Wright Medical Group NV (NASDAQ:WMGI)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Wright Medical Group NV Charts.